Cold Call

Latest Episodes:

Elon Musk’s Twitter Takeover: Lessons in Strategic Change Jun 20, 2023

Show notes

In late October 2022, Elon Musk officially took Twitter private and became the company’s majority shareholder, finally ending a months-long acquisition saga. He appointed himself CEO and brought in his own team to clean house.

Musk needed to take decisive steps to succeed against the major opposition to his leadership from both inside and outside the company. Twitter employees circulated an open letter protesting expected layoffs, advertising agencies advised their clients to pause spending on Twitter, and EU officials considered a broader Twitter ban. What short-term actions should Musk take to stabilize the situation, and how should he approach long-term strategy to turn around Twitter?

Harvard Business School assistant professor Andy Wu and co-author Goran Calic, associate professor at McMaster University’s DeGroote School of Business, discuss Twitter as a microcosm for the future of media and information in their case, “Twitter Turnaround and Elon Musk.”

The Opioid Crisis, CEO Pay, and Shareholder Activism Jun 06, 2023

Show notes

In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices, which critics alleged had contributed to the opioid crisis in the U.S. The $6.6 billion global settlement caused a net loss larger than the cumulative net income earned during the tenure of the company’s CEO, which began in 2011.

In addition, AmerisourceBergen’s legal and financial troubles were accompanied by shareholder demands aimed at driving corporate governance changes in companies in the opioid supply chain. Determined to hold the company’s leadership accountable, the shareholders launched a campaign in early 2021 to reject the pay packages of executives.

Should the board reduce the executives’ pay, as of means of improving accountability? Or does punishing the AmerisourceBergen executives for paying the settlement ignore the larger issue of a business’s responsibility to society?

Harvard Business School professor Suraj Srinivasan discusses executive compensation and shareholder activism in the context of the U.S. opioid crisis in his case, “The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen.”

The Entrepreneurial Journey of China’s First Private Mental Health Hospital May 23, 2023

Show notes

The city of Wenzhou in southeastern China is home to the country’s largest privately owned mental health hospital group, the Wenzhou Kangning Hospital Co, Ltd. It’s an example of the extraordinary entrepreneurship happening in China’s healthcare space. But after its successful initial public offering (IPO), how will the hospital grow in the future?

Harvard Professor of China Studies William C. Kirby highlights the challenges of China’s mental health sector and the means company founder Guan Weili employed to address them in his case, Wenzhou Kangning Hospital: Changing Mental Healthcare in China.

Can Robin Williams’ Son Help Other Families Heal Addiction and Depression? May 09, 2023

Show notes

Zak Pym Williams, son of comedian and actor Robin Williams, had seen how mental health challenges, such as addiction and depression, had affected past generations of his family. Pym Williams was diagnosed with generalized anxiety disorder, depression, and post-traumatic stress disorder (PTSD) as a young adult and he wanted to break the cycle for his children. Although his children were still quite young, he began considering proactive strategies that could help his family’s mental health, and he wanted to share that knowledge with other families. But how can Pym Williams help people actually embrace those mental health strategies and services?

Harvard Business School professor Lauren Cohen discusses his case, “Weapons of Self Destruction: Zak Pym Williams and the Cultivation of Mental Wellness.”

Sweden’s Northvolt Electric Battery Maker: A Startup with a Mission Apr 28, 2023

Show notes

In Stockholm, Sweden an upstart battery maker, Northvolt, is trying to recreate the value chain for European car manufacturers making the switch to EVs. With two founders from Tesla and two experienced financiers at the helm, the company seems bound for success. But can they partner with government, scale fast enough, and truly be part of the climate solution?

Harvard Business School professor George Serafeim discusses what it takes to scale a business—the right people, in the right place, at the right time—with the aim of providing a climate solution in the case, “Northvolt, Building Batteries to Fight Climate Change.” As part of a new first-year MBA course at Harvard Business School, this case examines the central question: what is the social purpose of the firm?

Equity Bank CEO James Mwangi: Transforming Lives with Access to Credit Apr 27, 2023

Show notes

James Mwangi, CEO of Equity Bank, has transformed lives and livelihoods throughout East and Central Africa by giving impoverished people access to banking accounts and micro loans. He’s been so successful that in 2020 Forbes coined the term “the Mwangi Model.” But can we really have both purpose and profit in a firm?

Harvard Business School professor Caroline Elkins, who has spent decades studying Africa, explores how this model has become one that business leaders are seeking to replicate throughout the world in her case, “A Marshall Plan for Africa’: James Mwangi and Equity Group Holdings.”As part of a new first-year MBA course at Harvard Business School, this case examines the central question: what is the social purpose of the firm?

How Martine Rothblatt Started a Company to Save Her Daughter Apr 26, 2023

Show notes

When serial entrepreneur Martine Rothblatt (founder of Sirius XM) received her seven-year-old daughter’s diagnosis of Pulmonary Arterial Hypertension (PAH), she created United Therapeutics and developed a drug to save her life. When her daughter later needed a lung transplant, Rothblatt decided to take what she saw as the logical next step: manufacturing organs for transplantation.

Rothblatt’s entrepreneurial career exemplifies a larger debate around the role of the firm in creating solutions for society’s problems. If companies are uniquely good at innovating, what voice should society have in governing the new technologies that firms create?

Harvard Business School professor Debora Spar debates these questions in the case “Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams.” As part of a new first-year MBA course at Harvard Business School, this case examines the central question: what is the social purpose of the firm?

Using Design Thinking to Invent a Low-Cost Prosthesis for Land Mine Victims Apr 25, 2023

Show notes

Bhagwan Mahaveer Viklang Sahayata Samiti (BMVSS) is an Indian nonprofit famous for creating low-cost prosthetics, like the Jaipur Foot and the Stanford-Jaipur Knee. Known for its patient-centric culture and its focus on innovation, BMVSS has assisted more than one million people, including many land mine survivors.

How can founder D.R. Mehta devise a strategy that will ensure the financial sustainability of BMVSS while sustaining its human impact well into the future? Harvard Business School Dean Srikant Datar discusses the importance of design thinking in ensuring a culture of innovation in his case, “BMVSS: Changing Lives, One Jaipur Limb at a Time.”

Our All-Time Favorite Episodes of Cold Call Apr 24, 2023

Show notes

Cold Call is celebrating 200 episodes with a special five-part series during the week of April 24, 2023. Each day that week, Cold Call will release a new episode. To kick off the week-long celebration, the show’s producers have each picked their three favorite episodes from the archives for listeners to revisit.

Host Brian Kenny recommends:

Can Gimlet Turn a Podcast Network into a Disruptive Platform? with professors John Deighton and Jeffrey Rayport
Employee Performance vs. Company Values: A Manager’s Dilemma with former Dean Nitin Nohria
Global Ocean Trust: Protecting the Blue Planet in New Ways with professor Rosabeth Moss Kanter and protagonist Torsten Thiele

Show producer Robin Passias recommends:

The Delicious History of Hershey Chocolate with professor Nancy Koehn
Is Happiness at Work Really Attainable? with professor Francesca Gino and protagonist Simón Cohen
Procter & Gamble’s Lean Innovation Transformation with assistant professor Emily Truelove

Audio Engineer Craig McDonald recommends:

Baseball’s Billy Beane Shows Companies the Power of Data with Dean Srikant Datar
How Wegmans Became a Leader in Improving Food Safety with professor emeritus Ray Goldberg
A Lesson from Google: Can AI Bias Be Monitored Internally? with professor Tsedal Neeley

Cases discussed in these episodes are available online:

A Rose by Any Other Name: Supply Chains and Carbon Emissions in the Flower Industry Apr 11, 2023

Show notes

Headquartered in Kitengela, Kenya, Sian Flowers exports roses to Europe. Because cut flowers have a limited shelf life and consumers want them to retain their appearance for as long as possible, Sian and its distributors used international air cargo to transport them to Amsterdam, where they were sold at auction and trucked to markets across Europe. But when the Covid-19 pandemic caused huge increases in shipping costs, Sian launched experiments to ship roses by ocean using refrigerated containers.

The company reduced its costs and cut its carbon emissions, but is a flower that travels halfway around the world truly a “low-carbon rose”? Harvard Business School professors Willy Shih and Mike Toffel debate these questions and more in their case, “Sian Flowers: Fresher by Sea?”

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected